Clinical trial
Targeting Acute Congestion With Tolvaptan in Congestive Heart Failure
NCT01644331
Study timeline
Study start (unknown)2012-10-01Date precision: month
Registry last updated2017-04-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Heart Failureunresolved
Dyspneaunresolved
Interventions
TolvaptanDRUG · verified · RxNorm: tolvaptan
PlaceboDRUG
Sponsors & collaborators
Duke Universitylead sponsor
Mapped research locations
CincinnatiOhio, United States2ChicagoIllinois, United States1DallasTexas, United States1AtlantaGeorgia, United States1DurhamNorth Carolina, United States1IndianapolisIndiana, United States1MinneapolisMinnesota, United States1AuroraColorado, United States1CharlotteNorth Carolina, United States1Chapel HillNorth Carolina, United States1The BronxNew York, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01644331 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.